Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Multidrug resistance of malignant tumors].

Orvosi hetilap - 6 Oct 1991

Bak M

Abstract excerpt

The development of resistance to chemotherapy is a major problem in the treatment of malignant tumors. Clinically, this is characterized by short periods of remission and failure to respond to subsequent therapy. Multidrug-resistance or pleiotropic resistance describes the simultaneous expression of cellular resistance to a vide range of structurally unrelated drugs (e.g. alkaloids, anthracyclines, antibiotics,...

Topics

ATP Binding Cassette Transporter, Subfamily B, Member 1
Antibodies, Monoclonal
Antineoplastic Combined Chemotherapy Protocols
Drug Resistance
Humans
Immunohistochemistry
Membrane Glycoproteins
Neoplasm Proteins
Neoplasms
Phenotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 1682863

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 29 Aug 2026. Prepared record publication-1682863-2026-08-29.1. Manifest publication-graph-cohort-2026-08-29.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 29 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Multidrug resistance of malignant tumors].PMID 1682863Read ↗

[Multidrug or pleiotropic resistance].Semantic proximity Read ↗

[Multiple drug resistance].Semantic proximity Read ↗

Pleiotropic, multidrug-resistant phenotype and P-glycoprotein: a review.Semantic proximity Read ↗

[MDR (Multiple Drug Resistant) type of resistance to chemotherapy in clinical practice].Semantic proximity Read ↗

[Multiple drug resistance--theoretical and clinical aspects].Semantic proximity Read ↗

[Resistance to chemotherapeutic agents in the treatment of cancer. Emphasizing the multiresistant phenotype].Semantic proximity Read ↗

[Resistance to chemotherapy: current progress].Semantic proximity Read ↗

What does Multidrug Resistance (MDR) Expression Mean in the Clinic?Semantic proximity Read ↗

New mechanisms of multidrug resistance: an introduction to the Cancer Drug Resistance special collectionSemantic proximity Read ↗

[Expression of P-glycoprotein 170 (GP 170) and drug resistance in human cancers].Semantic proximity Read ↗

[The multidrug resistance phenotype: some morphological and biological characteristics except efflux pump].Semantic proximity Read ↗

[Resistance to anticancer drugs].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.